Torrent Pharmaceuticals Q2 FY27 net profit 9.6% lower
Key Highlights
Torrent Pharmaceuticals Q2 FY27 results show a net profit of ₹534 crore. Revenue from operations for the quarter reached ₹4,979 crore.
Updated: Friday 23 October 2026
- Torrent Pharmaceuticals reported a net profit of ₹534 crore in Q2 FY27, 9.64% lower than a year earlier.
- from operations: ₹4,979 crore, 50.79% higher than a year earlier.
- Net profit margin: 10.73% (17.90% a year earlier).
- Shares: ₹4,524.40, −1.97% at 15:51 IST on 23 Oct 2026.
Torrent Pharmaceuticals Q2 FY27 results show a net profit of ₹534 crore, which is 9.64% lower than a year earlier. The company reported this figure for the quarter ended 30 September 2026.
Revenue from operations reached ₹4,979 crore, 50.79% higher than a year earlier. These results were filed on Friday 23 October at 4:30 pm IST.
Torrent Pharmaceuticals Q2 FY27 results at a glance
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Q1 FY27 | Change |
|---|---|---|---|---|---|
| Revenue from operations | 4,979 | 3,302 | +50.79% | 4,921 | +1.18% |
| 737 | 791 | −6.83% | 733 | +0.55% | |
| Net profit | 534 | 591 | −9.64% | 566 | −5.65% |
| Earnings per share | ₹14.04 | ₹17.46 | −19.60% | ₹16.72 | −16.05% |
| Net profit as a share of revenue | 10.73% | 17.90% | – | 11.50% | – |
The company reported a profit before tax of ₹737 crore for the quarter. Net profit was 10.73% of revenue, compared to 17.90% in Q2 FY26 and 11.50% in Q1 FY27. For the half-year to 30 September 2026, the company recorded a net profit of ₹1,100 crore, which is 3.42% lower than the same period a year earlier.
Torrent Pharmaceuticals half-year figures
| ₹ crore | Half-year | Same period a year earlier | Change |
|---|---|---|---|
| Revenue from operations | 9,900 | 6,480 | +52.78% |
| Net profit | 1,100 | 1,139 | −3.42% |
Torrent Pharmaceuticals share price after the results
| Share price (15:51 IST) | ₹4,524.40 |
| Previous close | ₹4,615.30 |
| Change | −₹90.90 (−1.97%) |
| Nifty Pharma | −1.04% |
| −0.39% |
The share price of Torrent Pharmaceuticals was ₹4,524.40 on 23 October 2026. This represents a 1.97% decline from the previous close of ₹4,615.30. The results were filed at 16:30 IST, which was after the market session closed for the day.
How Torrent Pharmaceuticals shares moved on its earlier results
| Quarter | Results filed | Window | Change |
|---|---|---|---|
| Q1 FY27 | 30 Jul 2026 | 30 Jul 2026 to 31 Jul 2026 | +5.15% |
| Q4 FY26 | 22 May 2026 | 22 May 2026 to 25 May 2026 | +1.93% |
The share price moved by 5.15% from the last close before the filing to the next close for Q1 FY27 results. For Q4 FY26, the share price moved by 1.93% between the last close before the filing and the next close.
Torrent Pharmaceuticals Q2 FY27 results: FAQs
What were Torrent Pharmaceuticals’s Q2 FY27 results?
Torrent Pharmaceuticals reported a net profit of ₹534 crore and revenue from operations of ₹4,979 crore for the quarter ended 30 September 2026 (consolidated figures). Net profit was 9.64% lower than a year earlier and revenue from operations was 50.79% higher than a year earlier.
When did Torrent Pharmaceuticals announce its Q2 FY27 results?
The results were filed with the exchange at Fri 23 Oct, 4:30 pm IST.
What was Torrent Pharmaceuticals’s net profit margin in Q2 FY27?
Net profit was 10.73% of revenue, against 17.90% in the same quarter a year earlier.
What is the Torrent Pharmaceuticals share price after the results?
₹4,524.40, −1.97% from the previous close of ₹4,615.30, at 15:51 IST on Friday 23 October 2026. The results were filed at 16:30 IST, after the session closed; this move came before they were published.
Results are the company’s filings to the exchanges; prices are from the National Stock Exchange. Calculations are by ThePip. For information only; not investment advice.